The partial alpha emitting lanthanide isotope 149 Tb seems to have a great potential in systemic radioimmuno therapy (RIT), especially when single cells in transit or circulation are targeted. The isotope 149 Tb has a half life of 4.118 h and decays by alpha emission (3.97 MeV, 17%) EC-process (76%) and β + -emission (7%). In this paper, we analyze the possible production routes: light- and heavy ion induced nuclear reactions and p-induced spallation. The excitation functions for light- and heavy ion induced reactions have been calculated using the ALICE91 code. The direct nuclear reaction 152 Gd ( p , 4 n ) 149 Tb was found to be the most promising production path. Alternatively, the indirect reaction 142 Nd ( 12 C, 5 n ) 149 Dy → 149 Tb seems to be much more suitable compared to the reaction on the mono-isotopic target element 141 Pr 12 C, 4 n ) 149 Tb. In this case, both, the production yield of 149 Tb and the radionuclidic purity are considerably lower, compared to the ( p , 4 n )-reaction. In preliminary experiments we produced 149 Tb via the indirect reaction Nd ( 12 C, 5 n ) 149 Dy → 149 Tb (108 MeV 12 C +6 ions and 1 particle-µA) at the U-200 heavy ion cyclotron at the FLNR of the JINR Dubna. From a 1.25 h irradiation of a 12 mg/cm 2 nat Nd 2 O 3 target, we obtained 2.7 MBq of 149 Tb (70 µCi) at 20 min EOB. This allows the conclusion, that a dedicated cyclotron equipped with a modern ECR-ion source, providing high ion currents would allow the continuous production of batches of the order of 10–20 GBq of 149 Tb for routine RI-therapy. The lower cross section of the spallation process can be compensated by using very thick targets. On-line mass separation technique provides high purity isotopically clean 149 Tb preparations, independently on the production route chosen. At the ISOLDE facility at CERN, we prepared batches of up to 500 MBq 149 Tb by combining on-line mass separation process followed by a cation exchange chromatography process using α-HIBA as eluent. The obtained 149 Tb preparations showed excellent behavior in labeling of chelated monoclonal antibodies.
Contents
-
Requires Authentication UnlicensedProduction routes of the alpha emitting 149Tb for medical applicationLicensedSeptember 25, 2009
-
Requires Authentication UnlicensedSelective dissolution of Am in basic media in the presence of ferricyanide ions: a mechanistic and structural study on Am(V) and Am(VI) compoundsLicensedSeptember 25, 2009
-
Requires Authentication UnlicensedThe kinetics and mechanism of the reduction of neptunium (VI) ions by uranium (IV) ions in nitric acidLicensedSeptember 25, 2009
-
Requires Authentication UnlicensedDetermination of 237Np at trace level: evaluation of various analytical proceduresLicensedSeptember 25, 2009
-
Requires Authentication UnlicensedPreparation of U(VI) and Th(IV) α-sources from calcium nitrate solutions by combining solvent extraction and electrodeposition proceduresLicensedSeptember 25, 2009
-
Requires Authentication UnlicensedImmobilization of actinide ions in thin layers of polypyrrole/polyacrylamidoglycolic acid (PPy/PAGA) composite. Application to the preparation of alpha spectrometry sourcesLicensedSeptember 25, 2009
-
Requires Authentication UnlicensedSeparation and purification of Th from U by ammonium molybdophosphate from nitric solutionsLicensedSeptember 25, 2009
-
Requires Authentication UnlicensedComplexation and luminescence spectroscopic studies of europium(III) with polymaleic acidLicensedSeptember 25, 2009
-
Requires Authentication UnlicensedLiquid-liquid extraction of Hf(IV) from nitric acid with dibutylsulfoxide in cyclohexaneLicensedSeptember 25, 2009
-
Requires Authentication UnlicensedMultitracer study on the uptake mechanism of yttrium and rare earth elements by autumn fernLicensedSeptember 25, 2009